| Serial Number | 98350278 |
| Word Mark | 8 |
| Filing Date | Wednesday, January 10, 2024 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Monday, March 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 13, 2024 |
| Description of Mark | The mark consists of a horizontal figure 8 with a pointed design protruding from the upper left corner, and four interwoven short lines inside an oval in the right. |
| Pseudo Mark | EIGHT |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Active pharmaceutical ingredients (APIs), namely, oligonucleotide APIs for use in the manufacture of pharmaceuticals for treating tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 10, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | Tuesday, March 16, 2021 |
| First Use In Commerce Date | Sunday, May 7, 2023 |
| Party Name | ARGORNA PHARMACEUTICALS CO., LTD |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Guangzhou, Guangdong - CN |
| Party Name | ARGORNA PHARMACEUTICALS CO., LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Guangzhou, Guangdong - CN |
| Event Date | Event Description |
| Wednesday, January 10, 2024 | NEW APPLICATION ENTERED |
| Wednesday, May 1, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, May 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, June 17, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, July 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 13, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 13, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 8, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 14, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, January 14, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, January 14, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, January 14, 2025 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Tuesday, January 14, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, January 16, 2025 | USE AMENDMENT FILED |
| Thursday, January 16, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Friday, March 21, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, March 21, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, March 24, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, March 24, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |